Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma

9Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Osteosarcoma is the most common primary malignant bone tumor in young adult, which is prone to early metastasis and poor prognosis. The current treatment methods need to be improved. Circular RNA is a covalently blocked circular, non-coding RNA that plays an essential role in the occurrence, development, clinical diagnosis, and treatment of various diseases. Recently, an increasing number of circRNAs have been identified in osteosarcoma. Understanding its role in osteosarcoma is conducive to the early detection, diagnosis, and treatment of osteosarcoma. In this paper, we reviewed the mechanism of action of circular RNA in the occurrence and development of osteosarcoma and its clinical application in recent years.

Cite

CITATION STYLE

APA

Wu, H., Zheng, S., He, Q., & Li, Y. (2023). Recent Advances of Circular RNAs as Biomarkers for Osteosarcoma. International Journal of General Medicine. Dove Medical Press Ltd. https://doi.org/10.2147/IJGM.S380834

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free